MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.
Mutual FundPosition in RLMD — Relmada Therapeutics, Inc.
CIK 1705339
CAUSEWAY BAY, K3
Position in RLMD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$300,051
New position
Shares Held
43,360
first reported quarter
Ownership
0.041%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#84
of 126 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. holds $446,316,962 across 286 Biotechnology names. RLMD ranks #166 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
150,692 | $74,853,236 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
59,595 | $37,159,864 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
63,265 | $19,044,662 | |
| 4 | RPRX |
Royalty Pharma plc
|
259,390 | $14,543,997 | |
| 5 | TWST |
Twist Bioscience Corp
|
100,108 | $10,299,110 | |
| 6 | INCY |
Incyte Corp
|
83,084 | $9,418,401 | |
| 7 | PRAX |
Praxis Precision Medicines, Inc.
|
27,185 | $9,101,265 | |
| 8 | MRNA |
Moderna, Inc.
|
106,564 | $7,462,676 |
All Filings in RLMD
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $300,051 | 43,360 | Shares | Defined | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||